Document is current
Any future updates will be listed below
-
Authors
Hoeg-Jensen, Thomas https://orcid.org/0000-0003-3882-6345
Kruse, Thomas https://orcid.org/0000-0002-5756-753X
Brand, Christian L. https://orcid.org/0000-0002-7355-4448
Sturis, Jeppe https://orcid.org/0000-0001-9938-5278
Fledelius, Christian
Nielsen, Peter K.
Nishimura, Erica https://orcid.org/0000-0001-5741-3648
Madsen, Alice R. https://orcid.org/0009-0004-4624-7794
Lykke, Lennart
Halskov, Kim S.
Koščová, Simona
Kotek, Vladislav
Davis, Anthony P. https://orcid.org/0000-0001-5213-624X
Tromans, Robert A. https://orcid.org/0009-0008-8894-6963
Tomsett, Michael https://orcid.org/0009-0009-3246-4540
Peñuelas-Haro, Guillem
Leonard, Daniel J. https://orcid.org/0000-0003-2503-0890
Orchard, Michael G.
Chapman, Andy
Invernizzi, Gaetano
Johansson, Eva https://orcid.org/0000-0001-9330-5169
Granata, Daniele
Hansen, Bo F.
Pedersen, Thomas A.
Kildegaard, Jonas
Pedersen, Karen-Margrethe https://orcid.org/0009-0004-0386-2391
Refsgaard, Hanne H. F. https://orcid.org/0000-0002-4996-4084
Alifrangis, Lene https://orcid.org/0000-0002-5356-6484
Fels, Johannes J. https://orcid.org/0000-0002-6616-6746
Neutzsky-Wulff, Anita V.
Sauerberg, Per
Slaaby, Rita https://orcid.org/0000-0002-2038-8466
- License Information
-
More Information
Article History
Received: 1 May 2023
Accepted: 12 September 2024
First Online: 16 October 2024
Competing interests
: T.H.-J., T.K., C.L.B., J.S., C.F., P.K.N., E.N., A.R.M., L.L., K.S.H., G.I., E.J., D.G., B.F.H., T.A.P., J.K., K.-M.P., H.H.F.R., L.A., J.J.F., A.V.N.-W., P.S. and R.S. are current or previous employees and shareholders of Novo Nordisk. A.P.D., R.A.T., M.T., M.G.O. and A.C. are listed as inventors on patent WO2018167503 (Davis, A. et al., macrocyclic compounds, 20 September 2018). T.H.-J., T.K., A.R.M., A.P.D., A.C. and P.S. are listed as inventors on patent WO2020058322 (Hoeg-Jensen, T. et al., glucose sensitive insulins and uses thereof, 26 March 2020). T.H.-J., T.K., A.R.M., L.L., K.S.H., A.P.D., M.T., A.C., P.S. and R.S. are listed as inventors on patent WO2023144240 (Hoeg-Jensen, T. et al., glucose sensitive insulin derivatives and uses thereof, 3 August 2023). The other authors declare no competing interests.
